Jacoline is the Technical Director for NICE Scientific Advice. She signs off and quality assures work across all services offered by the team and chairs national and parallel scientific advice meetings with medical device and pharmaceutical companies. She also works on the joint NICE, NHS England, and Department of Health and Social Care (DHSC) project that is developing new payment models for antimicrobials and is the chief analyst for NICE on the DHSC’s Health and Care Appraisal Working Group.
Previously, she worked in NICE’s Science Policy and Research team where she has led NICE’s work on the European Health Data and Evidence Network, HTA of histology independent cancer drugs, the use of patient preference studies in HTA, and several other pan-European research projects.
Before joining NICE in 2015, Jacoline worked at the European Medicines Agency where she was involved in the EMA registries initiative. Before that, she held postdoctoral positions at Erasmus University Rotterdam and Utrecht University in the Netherlands.
She has a PhD from Utrecht University, the Netherlands and has a MSc in health economics from Erasmus University Rotterdam, the Netherlands.